Tower Research Capital »

Tscan Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 11k 1.82
2025-06-30 $18k 13k 1.45
2025-03-31 $15k 11k 1.38
2024-12-31 $19k 6.2k 3.04
2024-09-30 $40k 8.0k 4.98
2024-06-30 $25k 4.2k 5.85
2023-03-31 $9.0k 4.1k 2.17
2022-12-31 $0 6.3k 0.00
2022-09-30 $18k 6.0k 2.98
2022-06-30 $28k 9.0k 3.08
2022-03-31 $0 7.9k 0.00
2021-12-31 $17k 3.8k 4.51